DrugsControl Media Services

News Detail

Delhi HC issues order favourable to Novartis in Ceritinib patent infringement case against Natco Pharma (14-01-2023)

New Delhi, 14 Jan 2023: In a new development to the long pending dispute between Swiss pharma major Novartis and Hyderabad-based pharma firm Natco Pharma, a single bench of Delhi High Court has issued an order restraining Natco, its management and distributors from infringing the......
View Details

Source : Pharmabiz
Natco Pharma Novartis Ceritinib IPAB Zykadia

Related News